Drug Discovery & Development Services
NCI's Division of Cancer Treatment and Diagnosis (DCTD) is uniquely positioned to support investigators via consultation and research services that accelerate drug discovery and development efforts.
DCTD provides resources and expertise to facilitate the development of innovative cancer therapeutics coupled with advancing knowledge gaps and potential treatment for rare diseases and unmet needs.
Past Drug Development Seminars
NCI Drug Development Workshop: How to Advance a Therapeutic Drug from Bench to Bedside
Date: July - December 2021
Summary: The goals of this workshop were to provide researchers who are interested in preclinical product development of anti-cancer agents with a guide to key IND-enabling activities and resources to facilitate successful translation from the lab to the clinic.
Workshop Recordings: Grand Overview; Preclinical Proof of Concept; Non-clinical Toxicology; Chemistry Manufacturing and Controls of Small Molecules; Development of Biological Products; Regulatory Considerations; Clinical Translation; Entrepreneurship; NCI Translational Resources and Programs
Contact: dtpinfo@mail.nih.gov
NCI Drug Development Workshop II: Specialized Topics in Preclinical Development of Small Molecule Cancer Drugs
Date: June 22 – July 28, 2023
Summary: This workshop complemented a related workshop entitled (NCI Drug Development Workshop: How to Advance a Therapeutic Candidate from Bench to Bedside) to summarize the critical considerations for the entire preclinical process, from early to late drug development of small molecule cancer drugs.
Recordings: Critical Considerations for Lead Optimization; Considerations for Advancing to Late Preclinical Development; Toxicity Studies for Small Molecules; Formulation of Small Molecules; Nanoparticle Delivery of Cancer Drugs; Good-to-Know IP Knowledge
Contact: Dr. Weiwei Chen, weiwei.chen@nih.gov
